Yuimedi

Founded in 2020 and based in Tokyo, Japan, Yuimedi, Inc. , d. b. a.

Yuimedi, operates as a company that provides infrastructure for accessing, standardizing, and using medical data, connecting medical institutions with data users, enabling data extraction, analytics, and software services to support research, clinical operations, and pharmaceutical activities across healthcare systems globally. In February 2026, Yuimedi, Inc. raised JPY 400 million in venture funding led by existing investor DG Daiwa Ventures with participation from other investors Chiba Dojo, Incubate Fund, D4V, Sumitomo Mitsui Trust Bank, HearstLab, and SMBC Venture Capital. The company provides its products, Yuicleaner, which is a no code data cleaning software specialising in medical data that works safely in a closed network.

Yuicleaner features include standardization, visualising errors, and supporting the anonymization process. The firm offers solutions such as data cleaning for medical data analysis, a network to connect data providers and researchers, and human resource development to assist people in the digital healthcare industry. As of February 2026, the company plans to expand data platforms, increase hospital partnerships, hire staff, improve data standardization, develop software products, and grow services for research and pharmaceutical use.